Qianyu Jing

NHC Key Laboratory Of Pulmonary Immunological Diseases
Guiyang, 550002, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Investigating the efficacy of propranolol in treating chronic stress combined with colorectal cancer in mice and its antitumor potential.

Investigating the efficacy of propranolol in treating chronic stress combined with colorectal cancer in mice and its antitumor potential.

Journal: European journal of pharmacology

Published: February 16, 2026

3M-052 combined inhibitory anti-TNFR2 synergistically suppresses colon cancer progression.

3M-052 combined inhibitory anti-TNFR2 synergistically suppresses colon cancer progression.

Journal: Frontiers in immunology

Published: November 18, 2025

Anti-TNFR2 antibody and HMGN1 combined with TIL cell therapy inhibits colorectal cancer progression by enhancing immune response.

Anti-TNFR2 antibody and HMGN1 combined with TIL cell therapy inhibits colorectal cancer progression by enhancing immune response.

Journal: Biochemical and biophysical research communications

Published: April 01, 2025

Development of an early prediction model for risk of influenza A and influenza B based on complete blood count examination.

Development of an early prediction model for risk of influenza A and influenza B based on complete blood count examination.

Journal: BMC infectious diseases

Published: March 06, 2025

Ansofaxine suppressed NSCLC progression by increasing sensitization to combination immunotherapy.

Ansofaxine suppressed NSCLC progression by increasing sensitization to combination immunotherapy.

Journal: International immunopharmacology

Published: September 21, 2024

PPDPF-mediated regulation of BCAA metabolism enhances mTORC1 activity and drives cholangiocarcinoma progression.

PPDPF-mediated regulation of BCAA metabolism enhances mTORC1 activity and drives cholangiocarcinoma progression.

Journal: Oncogene

Published: September 13, 2024

The combination of a PTP1B inhibitor, TNFR2 blocker, and PD‑1 antibody suppresses the progression of non‑small cell lung cancer tumors by enhancing immunocompetence.

The combination of a PTP1B inhibitor, TNFR2 blocker, and PD‑1 antibody suppresses the progression of non‑small cell lung cancer tumors by enhancing immunocompetence.

Journal: Oncology reports

Published: April 05, 2024

Combinational delivery of TLR4 and TLR7/8 agonist enhanced the therapeutic efficacy of immune checkpoint inhibitors to colon tumor.

Combinational delivery of TLR4 and TLR7/8 agonist enhanced the therapeutic efficacy of immune checkpoint inhibitors to colon tumor.

Journal: Molecular and cellular biochemistry

Published: December 24, 2023

Regulating Tumor-Associated Macrophage Polarization by Cyclodextrin-Modified PLGA Nanoparticles Loaded with R848 for Treating Colon Cancer.

Regulating Tumor-Associated Macrophage Polarization by Cyclodextrin-Modified PLGA Nanoparticles Loaded with R848 for Treating Colon Cancer.

Journal: International journal of nanomedicine

Published: December 08, 2023

Ansofaxine hydrochloride inhibits tumor growth and enhances Anti-TNFR2 in murine colon cancer model.

Ansofaxine hydrochloride inhibits tumor growth and enhances Anti-TNFR2 in murine colon cancer model.

Journal: Frontiers in pharmacology

Published: August 30, 2023

Psychological distress influences lung cancer: Advances and perspectives on the immune system and immunotherapy.

Psychological distress influences lung cancer: Advances and perspectives on the immune system and immunotherapy.

Journal: International immunopharmacology

Published: February 19, 2023

Anti-TNFR2 enhanced the antitumor activity of a new HMGN1/3M-052 stimulated dendritic cell vaccine in a mouse model of colon cancer.

Anti-TNFR2 enhanced the antitumor activity of a new HMGN1/3M-052 stimulated dendritic cell vaccine in a mouse model of colon cancer.

Journal: Biochemical and biophysical research communications

Published: February 06, 2023

Showing 1-12 of 12

Last Updated: 09/26/2026